The behaviour and phenotype of HDL and LDL carrier molecules can be altered in chronic conditions such as type II diabetes, where increased small dense LDL (sdLDL) molecules afford greater affinity for Lp-PLA2 [42]. This evidence concerns the gene PLA2G7 and type 2 diabetes mellitus.